Skip to main content

Publisher: Wiley-Blackwell on behalf of the International Society on Thrombosis and Haemostasis

Volume 7, Number 10, October 2009

Free Content Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men
pp. 1605-1611(7)
Authors: WANNAMETHEE, S. G.; WHINCUP, P. H.; SHAPER, A. G.; RUMLEY, A.; LENNON, L.; LOWE, G. D. O.

Favourites:
ADD

Free Content Marked reduction of early stent thrombosis with pre-hospital initiation of high-dose Tirofiban in ST-segment elevation myocardial infarction
pp. 1612-1618(7)
Authors: HEESTERMANS, A. A. C. M.; VAN WERKUM, J. W.; HAMM, C.; DILL, T.; GOSSELINK, A. T. M.; DE BOER, M. J.; VAN HOUWELINGEN, G.; HOORNTJE, J. C. A.; KOOPMANS, P. C.; TEN BERG, J. M.; VAN ‘T HOF, A. W. J.

Favourites:
ADD

Free Content Study of bioaccumulation of dalteparin at a therapeutic dose in patients with renal insufficiency
pp. 1629-1632(4)
Authors: SCHMID, P.; BRODMANN, D.; ODERMATT, Y.; FISCHER, A. G.; WUILLEMIN, W. A.

Favourites:
ADD

Free Content Clinical probability score and D-dimer estimation lack utility in the diagnosis of childhood pulmonary embolism
pp. 1633-1638(6)
Authors: BISS, T. T.; BRANDÃO, L. R.; KAHR, W. H. A.; CHAN, A. K. C.; WILLIAMS, S.

Favourites:
ADD
Favourites:
ADD

Free Content Variability of anti-PF4/heparin antibody results obtained by the rapid testing system ID-H/PF4-PaGIA
pp. 1649-1655(7)
Authors: SCHNEITER, S.; COLUCCI, G.; SULZER, I.; BARIZZI, G.; LÄMMLE, B.; ALBERIO, L.

Favourites:
ADD

Free Content Factor IX mutants with enhanced catalytic activity
pp. 1656-1662(7)
Authors: HARTMANN, R.; DOCKAL, M.; KAMMLANDER, W.; PANHOLZER, E.; NICOLAES, G. A.; FIEDLER, C.; ROSING, J.; SCHEIFLINGER, F.

Favourites:
ADD

Free Content Evaluation of lyophilized platelets as an infusible hemostatic agent in experimental non-compressible hemorrhage in swine
pp. 1663-1671(9)
Authors: HAWKSWORTH, J. S.; ELSTER, E. A.; FRYER, D.; SHEPPARD, F.; MORTHOLE, V.; KRISHNAMURTHY, G.; TOMORI, T.; BROWN, T. S.; TADAKI, D. K.

Favourites:
ADD

Free Content An assessment of the pathogenic significance of the R924Q von Willebrand factor substitution
pp. 1672-1679(8)
Authors: BERBER, E.; JAMES, P. D.; HOUGH, C.; LILLICRAP, D.

Favourites:
ADD

Free Content Identification of a VWF peptide antagonist that blocks platelet adhesion under high shear conditions by selectively inhibiting the VWF-collagen interaction
pp. 1680-1687(8)
Authors: SZANTO, T.; VANHOORELBEKE, K.; TOTH, G.; VANDENBULCKE, A.; TOTH, J.; NOPPE, W.; DECKMYN, H.; HARSFALVI, J.

Favourites:
ADD

Free Content Molecular basis of thrombomodulin activation of slow thrombin
pp. 1688-1695(8)
Authors: ADAMS, T. E.; LI, W.; HUNTINGTON, J. A.

Favourites:
ADD
Favourites:
ADD

Free Content IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura
pp. 1703-1710(8)
Authors: FERRARI, S.; MUDDE, G. C.; RIEGER, M.; VEYRADIER, A.; KREMER HOVINGA, J. A.; SCHEIFLINGER, F.

Favourites:
ADD

Free Content Platelet glycoprotein VI as a mediator of metastasis
pp. 1711-1712(2)
Author: FARNDALE, R. W.

Favourites:
ADD
Favourites:
ADD

Free Content Proteomic analysis of integrin αIIbβ3 outside-in signaling reveals Src-kinase-independent phosphorylation of Dok-1 and Dok-3 leading to SHIP-1 interactions
pp. 1718-1726(9)
Authors: SENIS, Y. A.; ANTROBUS, R.; SEVERIN, S.; PARGUIÑA, A. F.; ROSA, I.; ZITZMANN, N.; WATSON, S. P.; GARCÍA, A.

Favourites:
ADD

Free Content Prothrombotic effects of diclofenac on arteriolar platelet activation and thrombosis in vivo
pp. 1727-1735(9)
Authors: STRUTHMANN, L.; HELLWIG, N.; PIRCHER, J.; SOHN, H.-Y.; BUERKLE, M. A.; KLAUSS, V.; MANNELL, H.; POHL, U.; KRÖTZ, F.

Favourites:
ADD

Free Content Screening computer-assisted dosage programs for anticoagulation with warfarin and other vitamin K antagonists: minimum safety requirements for individual programs
pp. 1736-1736(1)
Authors: POLLER, L.; ROBERTS, C.; IBRAHIM, S.; KEOWN, M.; AGENO, W.; VAN DEN BESSELAAR, A. M. H. P.; FITZMAURICE, D.; HARENBERG, J.; KITCHEN, S.; LOWE, G.; MOIA, M.; PALARETI, G.; TRIPODI, A.; TURPIE, A. G. G.; JESPERSEN, J.

Favourites:
ADD

Free Content Update of the guidelines for lupus anticoagulant detection
pp. 1737-1740(4)
Authors: PENGO, V.; TRIPODI, A.; REBER, G.; RAND, J. H.; ORTEL, T. L.; GALLI, M.; DE GROOT, P. G.

Favourites:
ADD

Free Content Total knee arthroplasty in hemophilic arthropathy: efficiency of clotting factor usage in multijoint procedures
pp. 1741-1743(3)
Authors: SCHILD, F. J. A.; MAUSER-BUNSCHOTEN, E. P.; VERBOUT, A. J.; VAN RINSUM, A. C.; ROOSENDAAL, G.

Favourites:
ADD

Free Content Replication of findings on the association of genetic variation in 24 hemostasis genes and risk of incident venous thrombosis
pp. 1743-1746(4)
Authors: SMITH, N. L.; WIGGINS, K. L.; REINER, A. P.; LANGE, L. A.; CUSHMAN, M.; HECKBERT, S. R.; LUMLEY, T.; RICE, K. M.; FOLSOM, A. R.; PSATY, B. M.

Favourites:
ADD

Free Content CYP2C19*2 polymorphism is not the sole determinant of the response to clopidogrel: implications for its monitoring
pp. 1747-1749(3)
Authors: ALEIL, B.; LÉON, C.; CAZENAVE, J.-P.; GACHET, C.

Favourites:
ADD

Free Content von Willebrand factor cleaved from endothelial cells by ADAMTS13 remains ultralarge in size
pp. 1749-1752(4)
Authors: JIN, S.-Y.; SKIPWITH, C. G.; SHANG, D.; ZHENG, X. L.

Favourites:
ADD
Favourites:
ADD

Free Content Join ISTH
pp. 1757-1757(1)

Favourites:
ADD

Free Content Corrigendum
pp. 1758-1758(1)

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more